Annals of internal medicine
-
Review Meta Analysis
Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis.
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of antidiabetic drugs. ⋯ None.
-
The ideal blood pressure (BP) to decrease mortality rates in patients with non-dialysis-dependent chronic kidney disease (CKD) is unclear. ⋯ National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, and U.S. Department of Veterans Affairs.